Abstract
Objective: Left ventricular assist device (LVAD) destination therapy (DT) is a widely accepted standard in non-transplantable heart failure patients. However, the gain of quality of life (QOL) with this therapy is not fully evaluated. We studied the QOL in LVAD DT patients pre- and post-LVAD therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
